Identification of broadly reactive DR restricted epitopes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6413517
SERIAL NO

09009953

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is based on peptide binding specificities of HLA DR4w4, DR1 and DR7. Peptides binding to these DR molecules have a motif characterized by a large aromatic or hydrophobic residue in position 1 (Y, F, W, L, I, V, M) and a small, non charged residue in position 6 (S, T, C, A, P, V, I, L, M). In addition, allele-specific secondary effects and secondary anchors are defined, and these results were utilized to derive allele specific algorithms. By the combined use of such algorithms peptides capable of degenerate DR1, 4, 7 binding were identified.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMEXA INC5820 NANCY RIDGE DRIVE SUITE 100 SAN DIEGO CA 92121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sette, Alessandro La Jolla, CA 99 1392
Sidney, John San Diego, CA 52 851
Southwood, Scott Santee, CA 55 889

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation